
Chengshi Biotechnology is a leading mRNA drug research and development manufacturer, focusing on innovative healthcare solutions. The company specializes in mRNA design systems, LNP delivery systems, antigen AI prediction systems, GMP process development, and mRNA immunization services. With a commitment to quality and innovation, Chengshi aims to become a world-class medical technology enterprise, leveraging advanced research capabilities to improve health outcomes. The company has established a strong market position through strategic partnerships and investments, including a recent Pre-A funding round that valued the company at 200 million RMB.

Chengshi Biotechnology is a leading mRNA drug research and development manufacturer, focusing on innovative healthcare solutions. The company specializes in mRNA design systems, LNP delivery systems, antigen AI prediction systems, GMP process development, and mRNA immunization services. With a commitment to quality and innovation, Chengshi aims to become a world-class medical technology enterprise, leveraging advanced research capabilities to improve health outcomes. The company has established a strong market position through strategic partnerships and investments, including a recent Pre-A funding round that valued the company at 200 million RMB.